Chemoinformaics analysis of Limonene aldehyde
| Molecular Weight | 166.264 | nRot | 3 |
| Heavy Atom Molecular Weight | 148.12 | nRig | 7 |
| Exact Molecular Weight | 166.136 | nRing | 1 |
| Solubility: LogS | -2.963 | nHRing | 0 |
| Solubility: LogP | 3.09 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 31.1743 |
| nHD | 0 | BPOL | 18.9257 |
| QED | 0.465 |
| Synth | 3.814 |
| Natural Product Likeliness | 2.569 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.006 |
| CACO-2 | -4.407 |
| MDCK | 0.0000176 |
| BBB | 0.992 |
| PPB | 0.587448 |
| VDSS | 3.324 |
| FU | 0.205959 |
| CYP1A2-inh | 0.307 |
| CYP1A2-sub | 0.477 |
| CYP2c19-inh | 0.066 |
| CYP2c19-sub | 0.464 |
| CYP2c9-inh | 0.035 |
| CYP2c9-sub | 0.531 |
| CYP2d6-inh | 0.021 |
| CYP2d6-sub | 0.592 |
| CYP3a4-inh | 0.136 |
| CYP3a4-sub | 0.262 |
| CL | 12.313 |
| T12 | 0.396 |
| hERG | 0.011 |
| Ames | 0.069 |
| ROA | 0.012 |
| SkinSen | 0.964 |
| Carcinogencity | 0.884 |
| EI | 0.981 |
| Respiratory | 0.723 |
| NR-Aromatase | 0.01 |
| Antiviral | No |
| Prediction | 0.833632 |